Latest News and Press Releases
Want to stay updated on the latest news?
-
Vancouver, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Alcohol Use Disorder Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has...
-
Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
Vancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25,...
-
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Alcohol Use Disorder Market by Drug Class, Treatment Type, End User, Distribution Channel, Formulation - Global Forecast to 2030" report has been added...
-
With more than 100 federally recognized Native American tribes in California alone, Laguna Treatment Center is adding a new tribal recovery track.
-
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
-
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Global Disulfiram Market by Indication (Alcoholism Treatment, Co-occurring Disorders), Distribution Channel (Hospital Pharmacies, Online Pharmacies,...
-
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Alcohol Addiction - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive...